Bionovo prices public offering of common stock at $1.30 per share

[News]

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the pricing of its previously announced underwritten public offering, to sell up to 30,031,200 units at a price per unit of $1.00 for aggregate gross proceeds of approximately $30 million.

More... (http://www.news-medical.net/news/20110129/Bionovo-prices-public-offering-of-common-stock-at-24130-per-share.aspx)